| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 10930621 | Cytotherapy | 2014 | 10 Pages | 
Abstract
												Our study revealed that conventional CIK cells demonstrate no significant alloreactive potential but provide the strongest anti-tumor efficacy compared with manipulated CIK cells. Conventional CIK cells may therefore be tested in high numbers and short-term intervals in patients with impending relapse even after mismatched transplantation.
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Cell Biology
												
											Authors
												Eva Rettinger, Hermann Kreyenberg, Michael Merker, Selim Kuçi, Andre Willasch, Gesine Bug, Evelyn Ullrich, Winfried S. Wels, Halvard Bonig, Thomas Klingebiel, Peter Bader, 
											